1.
Edina BC, Rinaldi I. Effectiveness of Bendamustine-Rituximab Compared to R-CHOP/R-CVP as a First-Line Treatment of Indolent Non-Hodgkin’s Lymphoma or Mantle-Cell Lymphoma. Acta Med Indones [Internet]. 2022Jul.7 [cited 2025May12];54(2):316. Available from: https://actamedindones.org/index.php/ijim/article/view/1584